(Q36414191)

14 August 2017

1 reference

title

Role of urokinase inhibitors in choroidal neovascularization (English)

1 reference

14 August 2017

1 reference

Arup Das

1

1 reference

14 August 2017

Paul McGuire

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

Seminars in Ophthalmology

14 August 2017

published in

1 reference

14 August 2017

volume

21

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

23-27

1 reference

Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

uPAR: a versatile signalling orchestrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

The plasminogen activation system in tumor growth, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530500509366

10.1080/08820530500509366

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference